Jyoti Madhusoodanan is a freelance science writer based in Portland, Oregon.
Jyoti Madhusoodanan
From this contributor
Confusion at the crossroads of autism and hearing loss
Hearing difficulties and autism often overlap, exacerbating autism traits and complicating diagnoses.
Confusion at the crossroads of autism and hearing loss
Mutations in cancer gene tied to unique autism traits
Autistic people who carry mutations in a gene called PTEN have distinct behavioral and motor problems.
Mutations in cancer gene tied to unique autism traits
Analysis finds little evidence to support dietary interventions for autism
Special diets that eliminate certain foods or contain added supplements have minimal impact on autism traits, according to a review of 27 clinical trials.
Analysis finds little evidence to support dietary interventions for autism
Studies of autism treatments lack standard yardsticks
Clinical trials of autism treatments rarely use a consistent set of tools to measure efficacy, making it tough to compare the treatments.
Studies of autism treatments lack standard yardsticks
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.